

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.78470165 |
| 2 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.55110892 |
| 3 | locomotory exploration behavior (GO:0035641) | 5.52988922 |
| 4 | vocalization behavior (GO:0071625) | 5.29019791 |
| 5 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.17125790 |
| 6 | synaptic vesicle maturation (GO:0016188) | 5.04053019 |
| 7 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.98194502 |
| 8 | synaptic vesicle exocytosis (GO:0016079) | 4.82880322 |
| 9 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.79976456 |
| 10 | regulation of synapse structural plasticity (GO:0051823) | 4.77986122 |
| 11 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.77578046 |
| 12 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.75710387 |
| 13 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.74731485 |
| 14 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.54247243 |
| 15 | protein localization to synapse (GO:0035418) | 4.53442241 |
| 16 | synaptic transmission, dopaminergic (GO:0001963) | 4.43478004 |
| 17 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.41313025 |
| 18 | prepulse inhibition (GO:0060134) | 4.37472586 |
| 19 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.37339552 |
| 20 | neuron-neuron synaptic transmission (GO:0007270) | 4.37090729 |
| 21 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.36986997 |
| 22 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.34580884 |
| 23 | glutamate receptor signaling pathway (GO:0007215) | 4.33105385 |
| 24 | striatum development (GO:0021756) | 4.27584727 |
| 25 | neuronal action potential propagation (GO:0019227) | 4.26906653 |
| 26 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 4.26819603 |
| 27 | exploration behavior (GO:0035640) | 4.25048506 |
| 28 | synaptic transmission, glutamatergic (GO:0035249) | 4.21575657 |
| 29 | glutamate secretion (GO:0014047) | 4.20372898 |
| 30 | neuron cell-cell adhesion (GO:0007158) | 4.20172899 |
| 31 | neurotransmitter secretion (GO:0007269) | 4.10828667 |
| 32 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 4.08852727 |
| 33 | long-term memory (GO:0007616) | 4.06813204 |
| 34 | regulation of dendritic spine morphogenesis (GO:0061001) | 4.04108669 |
| 35 | presynaptic membrane organization (GO:0097090) | 4.00829964 |
| 36 | regulation of synaptic vesicle transport (GO:1902803) | 3.99419802 |
| 37 | auditory behavior (GO:0031223) | 3.98716002 |
| 38 | behavioral response to cocaine (GO:0048148) | 3.94765120 |
| 39 | long-term synaptic potentiation (GO:0060291) | 3.92360704 |
| 40 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.86295016 |
| 41 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.85817820 |
| 42 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.85509394 |
| 43 | positive regulation of membrane potential (GO:0045838) | 3.85479935 |
| 44 | transmission of nerve impulse (GO:0019226) | 3.84385146 |
| 45 | regulation of synaptic plasticity (GO:0048167) | 3.82746327 |
| 46 | regulation of female receptivity (GO:0045924) | 3.82428620 |
| 47 | response to histamine (GO:0034776) | 3.80837954 |
| 48 | regulation of postsynaptic membrane potential (GO:0060078) | 3.80771739 |
| 49 | C4-dicarboxylate transport (GO:0015740) | 3.79529386 |
| 50 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 3.75388005 |
| 51 | dendritic spine morphogenesis (GO:0060997) | 3.73142385 |
| 52 | regulation of glutamate secretion (GO:0014048) | 3.72925666 |
| 53 | gamma-aminobutyric acid transport (GO:0015812) | 3.71510741 |
| 54 | response to auditory stimulus (GO:0010996) | 3.70757155 |
| 55 | startle response (GO:0001964) | 3.69994101 |
| 56 | response to amphetamine (GO:0001975) | 3.68464440 |
| 57 | behavioral fear response (GO:0001662) | 3.68281130 |
| 58 | behavioral defense response (GO:0002209) | 3.68281130 |
| 59 | positive regulation of neurotransmitter transport (GO:0051590) | 3.67673128 |
| 60 | membrane depolarization during action potential (GO:0086010) | 3.63891061 |
| 61 | behavioral response to nicotine (GO:0035095) | 3.58188938 |
| 62 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.56984921 |
| 63 | neuromuscular process controlling balance (GO:0050885) | 3.56723174 |
| 64 | layer formation in cerebral cortex (GO:0021819) | 3.55953992 |
| 65 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.55124813 |
| 66 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.53986808 |
| 67 | female mating behavior (GO:0060180) | 3.50959910 |
| 68 | serotonin metabolic process (GO:0042428) | 3.42273135 |
| 69 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 3.41057397 |
| 70 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 3.41057397 |
| 71 | fear response (GO:0042596) | 3.40588458 |
| 72 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.40258550 |
| 73 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.39146993 |
| 74 | cellular potassium ion homeostasis (GO:0030007) | 3.38232231 |
| 75 | regulation of neurotransmitter uptake (GO:0051580) | 3.35567870 |
| 76 | dopamine receptor signaling pathway (GO:0007212) | 3.35062054 |
| 77 | neurotransmitter transport (GO:0006836) | 3.31624276 |
| 78 | regulation of dendritic spine development (GO:0060998) | 3.31202016 |
| 79 | positive regulation of synapse maturation (GO:0090129) | 3.29901574 |
| 80 | learning (GO:0007612) | 3.27343972 |
| 81 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.26280518 |
| 82 | positive regulation of synaptic transmission (GO:0050806) | 3.24348338 |
| 83 | activation of protein kinase A activity (GO:0034199) | 3.22859706 |
| 84 | neuromuscular synaptic transmission (GO:0007274) | 3.22336640 |
| 85 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.21514885 |
| 86 | regulation of protein kinase A signaling (GO:0010738) | 3.20984273 |
| 87 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.20820483 |
| 88 | neuronal ion channel clustering (GO:0045161) | 3.20666338 |
| 89 | regulation of neurotransmitter levels (GO:0001505) | 3.19746414 |
| 90 | mechanosensory behavior (GO:0007638) | 3.19317529 |
| 91 | primary amino compound metabolic process (GO:1901160) | 3.19174847 |
| 92 | membrane depolarization (GO:0051899) | 3.18820683 |
| 93 | visual learning (GO:0008542) | 3.17468700 |
| 94 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.16332309 |
| 95 | regulation of neurotransmitter transport (GO:0051588) | 3.15933933 |
| 96 | long term synaptic depression (GO:0060292) | 3.14998083 |
| 97 | regulation of neurotransmitter secretion (GO:0046928) | 3.14634606 |
| 98 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.13944837 |
| 99 | presynaptic membrane assembly (GO:0097105) | 3.13671775 |
| 100 | membrane hyperpolarization (GO:0060081) | 3.13146924 |
| 101 | neuron recognition (GO:0008038) | 3.12370356 |
| 102 | negative regulation of dendrite development (GO:2000171) | 3.12160613 |
| 103 | proline transport (GO:0015824) | 3.11855023 |
| 104 | negative regulation of amino acid transport (GO:0051956) | 3.11761371 |
| 105 | postsynaptic membrane organization (GO:0001941) | 3.11250451 |
| 106 | regulation of vesicle fusion (GO:0031338) | 3.11184458 |
| 107 | retinal cone cell development (GO:0046549) | 3.09993907 |
| 108 | central nervous system myelination (GO:0022010) | 3.09176968 |
| 109 | axon ensheathment in central nervous system (GO:0032291) | 3.09176968 |
| 110 | positive regulation of dendritic spine development (GO:0060999) | 3.08931767 |
| 111 | neuronal action potential (GO:0019228) | 3.08632290 |
| 112 | visual behavior (GO:0007632) | 3.06981761 |
| 113 | cAMP catabolic process (GO:0006198) | 3.06809366 |
| 114 | L-amino acid import (GO:0043092) | 3.05603649 |
| 115 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.04013163 |
| 116 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.03312580 |
| 117 | adult walking behavior (GO:0007628) | 3.02068062 |
| 118 | nucleobase catabolic process (GO:0046113) | 2.98791317 |
| 119 | synaptic vesicle endocytosis (GO:0048488) | 2.92838498 |
| 120 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.91006959 |
| 121 | behavioral response to ethanol (GO:0048149) | 2.89769183 |
| 122 | glycosphingolipid biosynthetic process (GO:0006688) | 2.88265080 |
| 123 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.87094750 |
| 124 | detection of light stimulus involved in visual perception (GO:0050908) | 2.87094750 |
| 125 | cochlea development (GO:0090102) | 2.86296627 |
| 126 | synaptic transmission (GO:0007268) | 2.85056262 |
| 127 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.80907469 |
| 128 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.77056314 |
| 129 | adult behavior (GO:0030534) | 2.73967092 |
| 130 | detection of calcium ion (GO:0005513) | 2.70501755 |
| 131 | axonal fasciculation (GO:0007413) | 2.69326151 |
| 132 | synapse assembly (GO:0007416) | 2.68717263 |
| 133 | cellular potassium ion transport (GO:0071804) | 2.66925445 |
| 134 | potassium ion transmembrane transport (GO:0071805) | 2.66925445 |
| 135 | action potential (GO:0001508) | 2.63756659 |
| 136 | auditory receptor cell stereocilium organization (GO:0060088) | 2.62384970 |
| 137 | phosphorelay signal transduction system (GO:0000160) | 2.62123165 |
| 138 | neurotransmitter uptake (GO:0001504) | 2.60807860 |
| 139 | neuromuscular process controlling posture (GO:0050884) | 2.60024885 |
| 140 | righting reflex (GO:0060013) | 2.55705924 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.75501397 |
| 2 | * GBX2_23144817_ChIP-Seq_PC3_Human | 3.59069698 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.26732405 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.23605309 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.11467733 |
| 6 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 3.10284177 |
| 7 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.77004689 |
| 8 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.74905957 |
| 9 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.74905957 |
| 10 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.69662828 |
| 11 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.67385204 |
| 12 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.61795146 |
| 13 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.57574053 |
| 14 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.53919891 |
| 15 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.51995114 |
| 16 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.50008664 |
| 17 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.47833906 |
| 18 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.29942877 |
| 19 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.22463815 |
| 20 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.20248084 |
| 21 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.19049350 |
| 22 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.17154756 |
| 23 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.16402811 |
| 24 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.16009229 |
| 25 | VDR_22108803_ChIP-Seq_LS180_Human | 2.12374384 |
| 26 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.03930330 |
| 27 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.02855208 |
| 28 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.83378045 |
| 29 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.82142598 |
| 30 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.80714807 |
| 31 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.72559339 |
| 32 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.71063565 |
| 33 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.70587269 |
| 34 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.70300193 |
| 35 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.68632694 |
| 36 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.67659340 |
| 37 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.65125731 |
| 38 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.64232081 |
| 39 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.60966465 |
| 40 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.49204105 |
| 41 | * ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.47552509 |
| 42 | P300_19829295_ChIP-Seq_ESCs_Human | 1.47488844 |
| 43 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.45323237 |
| 44 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.45323237 |
| 45 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.43864007 |
| 46 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.43539590 |
| 47 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.41966582 |
| 48 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.39384017 |
| 49 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.37396902 |
| 50 | * EWS_26573619_Chip-Seq_HEK293_Human | 1.36156890 |
| 51 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.35899937 |
| 52 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.34008339 |
| 53 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.32092908 |
| 54 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.31892947 |
| 55 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.30518763 |
| 56 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.29187411 |
| 57 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.29187411 |
| 58 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.28874483 |
| 59 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.26610933 |
| 60 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.25841531 |
| 61 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.25418944 |
| 62 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.25300943 |
| 63 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.24668667 |
| 64 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.23053221 |
| 65 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.23003596 |
| 66 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.22356755 |
| 67 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.21106525 |
| 68 | * FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.21042737 |
| 69 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.20301510 |
| 70 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.20156784 |
| 71 | * AR_19668381_ChIP-Seq_PC3_Human | 1.20112606 |
| 72 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.19688886 |
| 73 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.19289128 |
| 74 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.19039697 |
| 75 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.18667899 |
| 76 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.18565497 |
| 77 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.18054747 |
| 78 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.17029532 |
| 79 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.16503404 |
| 80 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.15646088 |
| 81 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.15448421 |
| 82 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.15409040 |
| 83 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.14887216 |
| 84 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.12375701 |
| 85 | * TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.11788345 |
| 86 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.10988778 |
| 87 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.10988778 |
| 88 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.09574172 |
| 89 | TP53_16413492_ChIP-PET_HCT116_Human | 1.08769452 |
| 90 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.08365875 |
| 91 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.08339099 |
| 92 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.07781525 |
| 93 | KDM2B_26808549_Chip-Seq_REH_Human | 1.06708093 |
| 94 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.06654680 |
| 95 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.06430592 |
| 96 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.06011518 |
| 97 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.04616190 |
| 98 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.04537862 |
| 99 | RXR_22108803_ChIP-Seq_LS180_Human | 1.03775027 |
| 100 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.03692401 |
| 101 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.03617257 |
| 102 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.03368154 |
| 103 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.03258569 |
| 104 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.02928580 |
| 105 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.02605172 |
| 106 | * RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.02580453 |
| 107 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.02502590 |
| 108 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.02104746 |
| 109 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.01703194 |
| 110 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.00869899 |
| 111 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.00690591 |
| 112 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.00591011 |
| 113 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.00457642 |
| 114 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.00435750 |
| 115 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.00422308 |
| 116 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.00066029 |
| 117 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.99646055 |
| 118 | FUS_26573619_Chip-Seq_HEK293_Human | 0.99133310 |
| 119 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.97797618 |
| 120 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.96746563 |
| 121 | JUN_21703547_ChIP-Seq_K562_Human | 0.93772989 |
| 122 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.92648739 |
| 123 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.91403748 |
| 124 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.90538094 |
| 125 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.90168915 |
| 126 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.89053257 |
| 127 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.88332131 |
| 128 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.87563024 |
| 129 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.87520614 |
| 130 | KDM2B_26808549_Chip-Seq_K562_Human | 0.87070916 |
| 131 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.84704975 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.57515354 |
| 2 | MP0002822_catalepsy | 6.09622609 |
| 3 | MP0003880_abnormal_central_pattern | 4.97730457 |
| 4 | * MP0003635_abnormal_synaptic_transmissio | 4.20084344 |
| 5 | MP0009745_abnormal_behavioral_response | 3.75775754 |
| 6 | MP0004270_analgesia | 3.50075321 |
| 7 | * MP0002063_abnormal_learning/memory/cond | 3.48513493 |
| 8 | MP0002064_seizures | 3.18638814 |
| 9 | MP0009046_muscle_twitch | 2.95333314 |
| 10 | MP0002572_abnormal_emotion/affect_behav | 2.92789187 |
| 11 | MP0001968_abnormal_touch/_nociception | 2.82242092 |
| 12 | MP0001486_abnormal_startle_reflex | 2.74100954 |
| 13 | MP0002272_abnormal_nervous_system | 2.60325423 |
| 14 | MP0005646_abnormal_pituitary_gland | 2.33454112 |
| 15 | MP0001501_abnormal_sleep_pattern | 2.32603492 |
| 16 | MP0001529_abnormal_vocalization | 2.32350589 |
| 17 | MP0005423_abnormal_somatic_nervous | 2.25043123 |
| 18 | MP0002734_abnormal_mechanical_nocicepti | 2.24570761 |
| 19 | MP0002736_abnormal_nociception_after | 2.15026514 |
| 20 | MP0001440_abnormal_grooming_behavior | 2.08294710 |
| 21 | MP0008877_abnormal_DNA_methylation | 2.07458630 |
| 22 | MP0009780_abnormal_chondrocyte_physiolo | 1.94800697 |
| 23 | MP0002909_abnormal_adrenal_gland | 1.93720369 |
| 24 | MP0005386_behavior/neurological_phenoty | 1.85195146 |
| 25 | MP0004924_abnormal_behavior | 1.85195146 |
| 26 | MP0001970_abnormal_pain_threshold | 1.81271168 |
| 27 | MP0002067_abnormal_sensory_capabilities | 1.79937524 |
| 28 | MP0002733_abnormal_thermal_nociception | 1.79790420 |
| 29 | MP0002735_abnormal_chemical_nociception | 1.77010654 |
| 30 | MP0008569_lethality_at_weaning | 1.74087595 |
| 31 | MP0003329_amyloid_beta_deposits | 1.70244301 |
| 32 | MP0002557_abnormal_social/conspecific_i | 1.69456716 |
| 33 | MP0001984_abnormal_olfaction | 1.67324905 |
| 34 | MP0004811_abnormal_neuron_physiology | 1.59099608 |
| 35 | MP0003879_abnormal_hair_cell | 1.51892810 |
| 36 | MP0004858_abnormal_nervous_system | 1.48187174 |
| 37 | MP0002102_abnormal_ear_morphology | 1.47607329 |
| 38 | MP0001188_hyperpigmentation | 1.47347188 |
| 39 | MP0002184_abnormal_innervation | 1.47288725 |
| 40 | MP0003646_muscle_fatigue | 1.46388905 |
| 41 | MP0000778_abnormal_nervous_system | 1.42673643 |
| 42 | MP0001905_abnormal_dopamine_level | 1.40208098 |
| 43 | MP0003633_abnormal_nervous_system | 1.39670651 |
| 44 | MP0001986_abnormal_taste_sensitivity | 1.37021127 |
| 45 | MP0004885_abnormal_endolymph | 1.34043970 |
| 46 | MP0002066_abnormal_motor_capabilities/c | 1.33900941 |
| 47 | MP0000955_abnormal_spinal_cord | 1.33754986 |
| 48 | MP0005253_abnormal_eye_physiology | 1.33053387 |
| 49 | MP0005409_darkened_coat_color | 1.32072981 |
| 50 | MP0004147_increased_porphyrin_level | 1.31761005 |
| 51 | MP0005645_abnormal_hypothalamus_physiol | 1.25197924 |
| 52 | * MP0002882_abnormal_neuron_morphology | 1.22983047 |
| 53 | MP0001502_abnormal_circadian_rhythm | 1.18532020 |
| 54 | MP0003121_genomic_imprinting | 1.18190201 |
| 55 | MP0003195_calcinosis | 1.17593436 |
| 56 | MP0003787_abnormal_imprinting | 1.17494389 |
| 57 | MP0006276_abnormal_autonomic_nervous | 1.17107461 |
| 58 | MP0008872_abnormal_physiological_respon | 1.15787426 |
| 59 | MP0003631_nervous_system_phenotype | 1.13143928 |
| 60 | MP0003075_altered_response_to | 1.12090996 |
| 61 | MP0008874_decreased_physiological_sensi | 1.11301255 |
| 62 | MP0006072_abnormal_retinal_apoptosis | 1.09998298 |
| 63 | MP0000013_abnormal_adipose_tissue | 1.09591352 |
| 64 | MP0003690_abnormal_glial_cell | 1.04259994 |
| 65 | MP0001177_atelectasis | 1.03495697 |
| 66 | MP0004142_abnormal_muscle_tone | 1.02961591 |
| 67 | * MP0002152_abnormal_brain_morphology | 0.97140566 |
| 68 | MP0005167_abnormal_blood-brain_barrier | 0.96374517 |
| 69 | MP0004133_heterotaxia | 0.95711763 |
| 70 | MP0002069_abnormal_eating/drinking_beha | 0.94710448 |
| 71 | MP0004085_abnormal_heartbeat | 0.93769051 |
| 72 | MP0002751_abnormal_autonomic_nervous | 0.88616196 |
| 73 | MP0005535_abnormal_body_temperature | 0.86343471 |
| 74 | MP0000751_myopathy | 0.84453081 |
| 75 | MP0000579_abnormal_nail_morphology | 0.82191587 |
| 76 | MP0002229_neurodegeneration | 0.82120189 |
| 77 | MP0000026_abnormal_inner_ear | 0.81356306 |
| 78 | MP0005551_abnormal_eye_electrophysiolog | 0.78755571 |
| 79 | MP0003122_maternal_imprinting | 0.77867984 |
| 80 | MP0010386_abnormal_urinary_bladder | 0.76921604 |
| 81 | MP0002090_abnormal_vision | 0.76774530 |
| 82 | MP0008961_abnormal_basal_metabolism | 0.76717285 |
| 83 | MP0000604_amyloidosis | 0.76447910 |
| 84 | MP0003634_abnormal_glial_cell | 0.74963568 |
| 85 | MP0000631_abnormal_neuroendocrine_gland | 0.73681893 |
| 86 | MP0005394_taste/olfaction_phenotype | 0.72311706 |
| 87 | MP0005499_abnormal_olfactory_system | 0.72311706 |
| 88 | MP0001485_abnormal_pinna_reflex | 0.72011806 |
| 89 | MP0002837_dystrophic_cardiac_calcinosis | 0.71719674 |
| 90 | MP0001963_abnormal_hearing_physiology | 0.71526121 |
| 91 | MP0004215_abnormal_myocardial_fiber | 0.70466177 |
| 92 | MP0000920_abnormal_myelination | 0.70247345 |
| 93 | MP0006292_abnormal_olfactory_placode | 0.70046403 |
| 94 | MP0003632_abnormal_nervous_system | 0.69864465 |
| 95 | MP0002234_abnormal_pharynx_morphology | 0.69392860 |
| 96 | MP0010234_abnormal_vibrissa_follicle | 0.67649458 |
| 97 | MP0003136_yellow_coat_color | 0.67424424 |
| 98 | MP0001664_abnormal_digestion | 0.66648964 |
| 99 | MP0004145_abnormal_muscle_electrophysio | 0.66084894 |
| 100 | MP0002876_abnormal_thyroid_physiology | 0.65566541 |
| 101 | MP0004742_abnormal_vestibular_system | 0.64818777 |
| 102 | MP0003137_abnormal_impulse_conducting | 0.64528694 |
| 103 | MP0003119_abnormal_digestive_system | 0.64014661 |
| 104 | MP0008789_abnormal_olfactory_epithelium | 0.63759746 |
| 105 | MP0003045_fibrosis | 0.63563573 |
| 106 | MP0005195_abnormal_posterior_eye | 0.63405971 |
| 107 | MP0003938_abnormal_ear_development | 0.63211433 |
| 108 | MP0004484_altered_response_of | 0.63193217 |
| 109 | MP0008875_abnormal_xenobiotic_pharmacok | 0.62560106 |
| 110 | MP0003890_abnormal_embryonic-extraembry | 0.62220596 |
| 111 | MP0003698_abnormal_male_reproductive | 0.61841730 |
| 112 | MP0000569_abnormal_digit_pigmentation | 0.61102724 |
| 113 | MP0002752_abnormal_somatic_nervous | 0.58673548 |
| 114 | MP0002638_abnormal_pupillary_reflex | 0.58626227 |
| 115 | MP0002928_abnormal_bile_duct | 0.58340694 |
| 116 | MP0000427_abnormal_hair_cycle | 0.58312055 |
| 117 | MP0004043_abnormal_pH_regulation | 0.58198411 |
| 118 | MP0003283_abnormal_digestive_organ | 0.57238600 |
| 119 | MP0004233_abnormal_muscle_weight | 0.53301065 |
| 120 | MP0001943_abnormal_respiration | 0.51961089 |
| 121 | MP0005171_absent_coat_pigmentation | 0.47086671 |
| 122 | MP0005166_decreased_susceptibility_to | 0.44821051 |
| 123 | MP0003956_abnormal_body_size | 0.44778601 |
| 124 | MP0005620_abnormal_muscle_contractility | 0.43914441 |
| 125 | MP0001765_abnormal_ion_homeostasis | 0.43514612 |
| 126 | MP0005595_abnormal_vascular_smooth | 0.43407053 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 8.89632915 |
| 2 | Myokymia (HP:0002411) | 8.09922514 |
| 3 | Focal seizures (HP:0007359) | 6.20276447 |
| 4 | Epileptic encephalopathy (HP:0200134) | 4.75913726 |
| 5 | Visual hallucinations (HP:0002367) | 4.73174305 |
| 6 | Atonic seizures (HP:0010819) | 4.36928156 |
| 7 | Febrile seizures (HP:0002373) | 4.31180328 |
| 8 | Absence seizures (HP:0002121) | 4.19829263 |
| 9 | Generalized tonic-clonic seizures (HP:0002069) | 3.97018780 |
| 10 | Action tremor (HP:0002345) | 3.96590904 |
| 11 | Dialeptic seizures (HP:0011146) | 3.95851298 |
| 12 | Hyperventilation (HP:0002883) | 3.92775079 |
| 13 | Progressive cerebellar ataxia (HP:0002073) | 3.84227924 |
| 14 | Broad-based gait (HP:0002136) | 3.81797207 |
| 15 | Poor eye contact (HP:0000817) | 3.75738190 |
| 16 | Anxiety (HP:0000739) | 3.61989793 |
| 17 | Dysdiadochokinesis (HP:0002075) | 3.59732896 |
| 18 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.59471945 |
| 19 | Gaze-evoked nystagmus (HP:0000640) | 3.48731122 |
| 20 | Depression (HP:0000716) | 3.45136847 |
| 21 | Impaired social interactions (HP:0000735) | 3.40569414 |
| 22 | Abnormal social behavior (HP:0012433) | 3.40569414 |
| 23 | Type II lissencephaly (HP:0007260) | 3.33090393 |
| 24 | Torticollis (HP:0000473) | 3.27954810 |
| 25 | Dysmetria (HP:0001310) | 3.27554670 |
| 26 | Annular pancreas (HP:0001734) | 3.21933580 |
| 27 | Truncal ataxia (HP:0002078) | 3.21704969 |
| 28 | Ankle clonus (HP:0011448) | 3.14452921 |
| 29 | Postural instability (HP:0002172) | 3.07639189 |
| 30 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.06169292 |
| 31 | Pancreatic fibrosis (HP:0100732) | 3.05295427 |
| 32 | Amblyopia (HP:0000646) | 3.04368119 |
| 33 | Resting tremor (HP:0002322) | 3.03530807 |
| 34 | Focal dystonia (HP:0004373) | 3.02360037 |
| 35 | True hermaphroditism (HP:0010459) | 3.01355910 |
| 36 | Scanning speech (HP:0002168) | 3.01091898 |
| 37 | Pancreatic cysts (HP:0001737) | 3.00791917 |
| 38 | Abnormal eating behavior (HP:0100738) | 2.97801743 |
| 39 | Supranuclear gaze palsy (HP:0000605) | 2.96333193 |
| 40 | Stereotypic behavior (HP:0000733) | 2.90684161 |
| 41 | Medial flaring of the eyebrow (HP:0010747) | 2.89400704 |
| 42 | Craniofacial dystonia (HP:0012179) | 2.78147883 |
| 43 | Gait imbalance (HP:0002141) | 2.74722104 |
| 44 | Dysmetric saccades (HP:0000641) | 2.73283674 |
| 45 | Impaired smooth pursuit (HP:0007772) | 2.70549343 |
| 46 | Hemiparesis (HP:0001269) | 2.66840377 |
| 47 | Urinary urgency (HP:0000012) | 2.66117809 |
| 48 | Bradykinesia (HP:0002067) | 2.64339768 |
| 49 | Cerebral inclusion bodies (HP:0100314) | 2.62181345 |
| 50 | Papilledema (HP:0001085) | 2.61532421 |
| 51 | Megalencephaly (HP:0001355) | 2.60950907 |
| 52 | Molar tooth sign on MRI (HP:0002419) | 2.57484865 |
| 53 | Abnormality of midbrain morphology (HP:0002418) | 2.57484865 |
| 54 | Progressive inability to walk (HP:0002505) | 2.56252713 |
| 55 | Neurofibrillary tangles (HP:0002185) | 2.55213870 |
| 56 | Thyroid-stimulating hormone excess (HP:0002925) | 2.54661111 |
| 57 | Nephronophthisis (HP:0000090) | 2.54653385 |
| 58 | Abnormality of the labia minora (HP:0012880) | 2.52402159 |
| 59 | Drooling (HP:0002307) | 2.50590993 |
| 60 | Excessive salivation (HP:0003781) | 2.50590993 |
| 61 | Impaired vibratory sensation (HP:0002495) | 2.50423840 |
| 62 | Epileptiform EEG discharges (HP:0011182) | 2.50027757 |
| 63 | Abnormality of binocular vision (HP:0011514) | 2.49206144 |
| 64 | Diplopia (HP:0000651) | 2.49206144 |
| 65 | Ankyloglossia (HP:0010296) | 2.45922883 |
| 66 | Spastic gait (HP:0002064) | 2.42640115 |
| 67 | Intention tremor (HP:0002080) | 2.41115110 |
| 68 | Cerebellar dysplasia (HP:0007033) | 2.40727700 |
| 69 | Congenital primary aphakia (HP:0007707) | 2.38693166 |
| 70 | Genital tract atresia (HP:0001827) | 2.38103068 |
| 71 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.37850070 |
| 72 | Aplasia of the phalanges of the hand (HP:0009802) | 2.37850070 |
| 73 | Aplasia involving bones of the extremities (HP:0009825) | 2.37850070 |
| 74 | Polydipsia (HP:0001959) | 2.36809386 |
| 75 | Abnormal drinking behavior (HP:0030082) | 2.36809386 |
| 76 | EEG with generalized epileptiform discharges (HP:0011198) | 2.33912089 |
| 77 | Abolished electroretinogram (ERG) (HP:0000550) | 2.32018238 |
| 78 | Genetic anticipation (HP:0003743) | 2.31441152 |
| 79 | Congenital stationary night blindness (HP:0007642) | 2.31332429 |
| 80 | Optic nerve hypoplasia (HP:0000609) | 2.30952934 |
| 81 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.29612151 |
| 82 | Vaginal atresia (HP:0000148) | 2.29529987 |
| 83 | Status epilepticus (HP:0002133) | 2.27913750 |
| 84 | Hemiplegia (HP:0002301) | 2.27079055 |
| 85 | Mutism (HP:0002300) | 2.26614617 |
| 86 | Lissencephaly (HP:0001339) | 2.24890700 |
| 87 | Insidious onset (HP:0003587) | 2.23043551 |
| 88 | Termporal pattern (HP:0011008) | 2.23043551 |
| 89 | Incomplete penetrance (HP:0003829) | 2.22907403 |
| 90 | Pointed chin (HP:0000307) | 2.21898478 |
| 91 | Hypsarrhythmia (HP:0002521) | 2.20739212 |
| 92 | Abnormality of the lower motor neuron (HP:0002366) | 2.20259485 |
| 93 | Abnormality of the renal medulla (HP:0100957) | 2.19851776 |
| 94 | Nephrogenic diabetes insipidus (HP:0009806) | 2.19257292 |
| 95 | Retinal dysplasia (HP:0007973) | 2.18233566 |
| 96 | Inability to walk (HP:0002540) | 2.14772958 |
| 97 | Absent speech (HP:0001344) | 2.13540485 |
| 98 | Lower limb amyotrophy (HP:0007210) | 2.11077309 |
| 99 | Lower limb muscle weakness (HP:0007340) | 2.10456259 |
| 100 | Intestinal atresia (HP:0011100) | 2.09902743 |
| 101 | Agitation (HP:0000713) | 2.09742725 |
| 102 | Abnormal EKG (HP:0003115) | 2.07919174 |
| 103 | Prolonged QT interval (HP:0001657) | 2.07813054 |
| 104 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 2.07101308 |
| 105 | Generalized myoclonic seizures (HP:0002123) | 2.02868234 |
| 106 | Abnormality of the renal cortex (HP:0011035) | 2.02548720 |
| 107 | Fetal akinesia sequence (HP:0001989) | 2.02471858 |
| 108 | Cystic liver disease (HP:0006706) | 2.00543918 |
| 109 | Blue irides (HP:0000635) | 1.98868667 |
| 110 | Attenuation of retinal blood vessels (HP:0007843) | 1.98598808 |
| 111 | Gait ataxia (HP:0002066) | 1.98507390 |
| 112 | Decreased central vision (HP:0007663) | 1.97646650 |
| 113 | Limb dystonia (HP:0002451) | 1.96774449 |
| 114 | Chronic hepatic failure (HP:0100626) | 1.96610019 |
| 115 | Pheochromocytoma (HP:0002666) | 1.90422816 |
| 116 | Abnormality of macular pigmentation (HP:0008002) | 1.85975128 |
| 117 | Oligodactyly (hands) (HP:0001180) | 1.82919305 |
| 118 | Rigidity (HP:0002063) | 1.82715579 |
| 119 | Spinal canal stenosis (HP:0003416) | 1.82455899 |
| 120 | Ventricular fibrillation (HP:0001663) | 1.82290716 |
| 121 | Abnormality of oral frenula (HP:0000190) | 1.82073230 |
| 122 | Psychosis (HP:0000709) | 1.81619280 |
| 123 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.81579113 |
| 124 | Lower limb asymmetry (HP:0100559) | 1.81573755 |
| 125 | Neuronal loss in central nervous system (HP:0002529) | 1.80772935 |
| 126 | Deeply set eye (HP:0000490) | 1.80361888 |
| 127 | Delusions (HP:0000746) | 1.79302996 |
| 128 | Pachygyria (HP:0001302) | 1.78454761 |
| 129 | Protruding tongue (HP:0010808) | 1.78240385 |
| 130 | Abnormality of saccadic eye movements (HP:0000570) | 1.77832411 |
| 131 | Polyphagia (HP:0002591) | 1.76672990 |
| 132 | Specific learning disability (HP:0001328) | 1.76288577 |
| 133 | Clonus (HP:0002169) | 1.75151484 |
| 134 | Clumsiness (HP:0002312) | 1.74074563 |
| 135 | Thickened helices (HP:0000391) | 1.73282201 |
| 136 | Polyuria (HP:0000103) | 1.73144139 |
| 137 | Poor coordination (HP:0002370) | 1.72652507 |
| 138 | Abnormality of salivation (HP:0100755) | 1.72438417 |
| 139 | Tubular atrophy (HP:0000092) | 1.72406239 |
| 140 | Pendular nystagmus (HP:0012043) | 1.71384671 |
| 141 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.70905653 |
| 142 | Obstructive sleep apnea (HP:0002870) | 1.70372716 |
| 143 | Spastic tetraplegia (HP:0002510) | 1.69685023 |
| 144 | Split foot (HP:0001839) | 1.68236535 |
| 145 | Widely spaced teeth (HP:0000687) | 1.67106284 |
| 146 | Dyskinesia (HP:0100660) | 1.64718572 |
| 147 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.64290264 |
| 148 | Syncope (HP:0001279) | 1.63069802 |
| 149 | Cerebral hypomyelination (HP:0006808) | 1.62608648 |
| 150 | Sclerocornea (HP:0000647) | 1.60910317 |
| 151 | Severe muscular hypotonia (HP:0006829) | 1.60855641 |
| 152 | Postaxial hand polydactyly (HP:0001162) | 1.59830821 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 6.56812889 |
| 2 | NTRK3 | 4.75347139 |
| 3 | FRK | 3.99153368 |
| 4 | MAP3K9 | 3.29245953 |
| 5 | BMPR1B | 2.89628588 |
| 6 | RIPK4 | 2.83894783 |
| 7 | MAP3K4 | 2.51127320 |
| 8 | MINK1 | 2.44223772 |
| 9 | DAPK2 | 2.41277053 |
| 10 | KSR2 | 2.37331380 |
| 11 | MAP4K2 | 2.21947961 |
| 12 | ADRBK2 | 2.13586943 |
| 13 | MAP2K7 | 2.10069885 |
| 14 | PRKD3 | 2.05706164 |
| 15 | NTRK2 | 2.05372748 |
| 16 | WNK3 | 2.00554908 |
| 17 | CAMKK1 | 1.92135239 |
| 18 | TNIK | 1.89861009 |
| 19 | CASK | 1.88787460 |
| 20 | NTRK1 | 1.88413522 |
| 21 | KSR1 | 1.85519613 |
| 22 | ARAF | 1.77210686 |
| 23 | MAP3K12 | 1.75969004 |
| 24 | MARK1 | 1.71448483 |
| 25 | DAPK1 | 1.70991790 |
| 26 | MAP3K13 | 1.69478110 |
| 27 | PAK6 | 1.67337123 |
| 28 | FES | 1.65193469 |
| 29 | INSRR | 1.64287299 |
| 30 | CDK5 | 1.54700157 |
| 31 | MAP2K4 | 1.54397415 |
| 32 | STK38L | 1.52441658 |
| 33 | PRPF4B | 1.45068460 |
| 34 | GRK1 | 1.36684708 |
| 35 | CAMKK2 | 1.33972182 |
| 36 | SIK2 | 1.28172364 |
| 37 | PLK2 | 1.27081480 |
| 38 | NUAK1 | 1.24807318 |
| 39 | MAP3K2 | 1.24579718 |
| 40 | BMPR2 | 1.23897798 |
| 41 | ACVR1B | 1.20042134 |
| 42 | RAF1 | 1.16954365 |
| 43 | PRKCG | 1.16494238 |
| 44 | PTK2B | 1.13138816 |
| 45 | GRK5 | 1.12370671 |
| 46 | STK38 | 1.11242111 |
| 47 | SGK494 | 1.09635541 |
| 48 | SGK223 | 1.09635541 |
| 49 | TAOK1 | 1.09525450 |
| 50 | SGK2 | 1.06826374 |
| 51 | WNK4 | 1.06652401 |
| 52 | CAMK2A | 1.05723959 |
| 53 | STK39 | 1.04392766 |
| 54 | CSNK1A1L | 1.02476153 |
| 55 | CSNK1G3 | 1.02388188 |
| 56 | CSNK1G1 | 0.99175767 |
| 57 | TYRO3 | 0.98536279 |
| 58 | CAMK2B | 0.94091830 |
| 59 | PNCK | 0.93831016 |
| 60 | MAPK13 | 0.90739555 |
| 61 | SIK3 | 0.90718905 |
| 62 | FGFR2 | 0.88605937 |
| 63 | DYRK2 | 0.86846029 |
| 64 | SGK3 | 0.86416721 |
| 65 | TRIM28 | 0.85722382 |
| 66 | CAMK1 | 0.85473276 |
| 67 | MKNK2 | 0.85071930 |
| 68 | SGK1 | 0.83840210 |
| 69 | TAOK3 | 0.83417200 |
| 70 | PKN1 | 0.82497841 |
| 71 | PINK1 | 0.81064114 |
| 72 | CDK18 | 0.80793566 |
| 73 | CDK19 | 0.78262914 |
| 74 | PRKCH | 0.75844169 |
| 75 | CDK15 | 0.75133645 |
| 76 | CDK14 | 0.74763672 |
| 77 | STK11 | 0.72447354 |
| 78 | UHMK1 | 0.70347689 |
| 79 | ADRBK1 | 0.69668545 |
| 80 | LMTK2 | 0.69069681 |
| 81 | FGR | 0.67519630 |
| 82 | TNK2 | 0.67441388 |
| 83 | PDPK1 | 0.67321790 |
| 84 | MAP3K1 | 0.66348257 |
| 85 | PDK1 | 0.66120701 |
| 86 | RET | 0.64565503 |
| 87 | CDK11A | 0.63575167 |
| 88 | MAP2K1 | 0.60613999 |
| 89 | MARK2 | 0.59650358 |
| 90 | PHKG2 | 0.59524958 |
| 91 | PHKG1 | 0.59524958 |
| 92 | NEK6 | 0.59057596 |
| 93 | CSNK1D | 0.58044748 |
| 94 | IRAK1 | 0.57795916 |
| 95 | AKT3 | 0.57424872 |
| 96 | MUSK | 0.57230401 |
| 97 | PRKCE | 0.55438423 |
| 98 | NME1 | 0.55185791 |
| 99 | BRAF | 0.52417631 |
| 100 | RPS6KA3 | 0.51699015 |
| 101 | DYRK1A | 0.51364553 |
| 102 | CSNK1A1 | 0.51173387 |
| 103 | OXSR1 | 0.50559717 |
| 104 | PRKCI | 0.50009268 |
| 105 | CAMK2D | 0.49828647 |
| 106 | TIE1 | 0.48408959 |
| 107 | ZAK | 0.47253402 |
| 108 | PRKCA | 0.46993761 |
| 109 | FYN | 0.46812074 |
| 110 | CAMK2G | 0.46804328 |
| 111 | PAK3 | 0.45217840 |
| 112 | BCR | 0.44499433 |
| 113 | PRKG1 | 0.44489604 |
| 114 | MAPK10 | 0.43372005 |
| 115 | PRKCZ | 0.43284193 |
| 116 | NEK1 | 0.41508837 |
| 117 | DMPK | 0.41211588 |
| 118 | MAPKAPK5 | 0.40890061 |
| 119 | FER | 0.40794374 |
| 120 | CAMK4 | 0.39587766 |
| 121 | PRKAA1 | 0.38300325 |
| 122 | ERBB3 | 0.38181901 |
| 123 | DAPK3 | 0.37564950 |
| 124 | PIK3CA | 0.37249082 |
| 125 | CSNK1E | 0.36793765 |
| 126 | PRKCB | 0.36548472 |
| 127 | MOS | 0.35440577 |
| 128 | ERBB2 | 0.35218449 |
| 129 | LATS2 | 0.34827113 |
| 130 | ALK | 0.33917665 |
| 131 | CSNK1G2 | 0.33517481 |
| 132 | PRKACA | 0.33387334 |
| 133 | MAP3K7 | 0.31199372 |
| 134 | PRKD2 | 0.31196226 |
| 135 | CDC42BPA | 0.31166607 |
| 136 | WNK1 | 0.31126989 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.70139870 |
| 2 | Olfactory transduction_Homo sapiens_hsa04740 | 3.16387566 |
| 3 | Long-term potentiation_Homo sapiens_hsa04720 | 2.90801274 |
| 4 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.85177836 |
| 5 | Circadian entrainment_Homo sapiens_hsa04713 | 2.83338491 |
| 6 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.81779338 |
| 7 | Morphine addiction_Homo sapiens_hsa05032 | 2.78347617 |
| 8 | GABAergic synapse_Homo sapiens_hsa04727 | 2.78014812 |
| 9 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.69948538 |
| 10 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.64788721 |
| 11 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.33507402 |
| 12 | Salivary secretion_Homo sapiens_hsa04970 | 2.29981644 |
| 13 | Cocaine addiction_Homo sapiens_hsa05030 | 2.09779882 |
| 14 | Renin secretion_Homo sapiens_hsa04924 | 2.03285787 |
| 15 | Cholinergic synapse_Homo sapiens_hsa04725 | 2.01562440 |
| 16 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.01397779 |
| 17 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.93748837 |
| 18 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.91765926 |
| 19 | Insulin secretion_Homo sapiens_hsa04911 | 1.90082070 |
| 20 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.86518694 |
| 21 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.85168830 |
| 22 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.82431281 |
| 23 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.74603732 |
| 24 | Long-term depression_Homo sapiens_hsa04730 | 1.74145691 |
| 25 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.71419815 |
| 26 | Taste transduction_Homo sapiens_hsa04742 | 1.68751775 |
| 27 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.63386193 |
| 28 | Gap junction_Homo sapiens_hsa04540 | 1.47665871 |
| 29 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.44948379 |
| 30 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.39498591 |
| 31 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.38320816 |
| 32 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.37164539 |
| 33 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.29928555 |
| 34 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.28209680 |
| 35 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.18084015 |
| 36 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.17747968 |
| 37 | Glioma_Homo sapiens_hsa05214 | 1.13506739 |
| 38 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.09383375 |
| 39 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.06617820 |
| 40 | * Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.06144415 |
| 41 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.05476958 |
| 42 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.05101771 |
| 43 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.04846197 |
| 44 | Melanogenesis_Homo sapiens_hsa04916 | 1.03325505 |
| 45 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.03306973 |
| 46 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.99980300 |
| 47 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.98637717 |
| 48 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.96283754 |
| 49 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.94764310 |
| 50 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.94360767 |
| 51 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.94004725 |
| 52 | Phototransduction_Homo sapiens_hsa04744 | 0.91804571 |
| 53 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.91459989 |
| 54 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.90484524 |
| 55 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.89319688 |
| 56 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.88902159 |
| 57 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.88596857 |
| 58 | Axon guidance_Homo sapiens_hsa04360 | 0.88096712 |
| 59 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.87136724 |
| 60 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.85792108 |
| 61 | Protein export_Homo sapiens_hsa03060 | 0.85613267 |
| 62 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.84781356 |
| 63 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.84428025 |
| 64 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.81672359 |
| 65 | * Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.78687619 |
| 66 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.78059897 |
| 67 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.77761913 |
| 68 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.77749858 |
| 69 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.76273416 |
| 70 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.74196603 |
| 71 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.73387695 |
| 72 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.71811871 |
| 73 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.70621047 |
| 74 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.69303979 |
| 75 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.68911881 |
| 76 | ABC transporters_Homo sapiens_hsa02010 | 0.67775826 |
| 77 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.66021602 |
| 78 | Alcoholism_Homo sapiens_hsa05034 | 0.64281898 |
| 79 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.64019854 |
| 80 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.63449533 |
| 81 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.63136729 |
| 82 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.63025085 |
| 83 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.61800974 |
| 84 | Peroxisome_Homo sapiens_hsa04146 | 0.61073588 |
| 85 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.60305183 |
| 86 | * Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.59857792 |
| 87 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.59756569 |
| 88 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.56619714 |
| 89 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.54802437 |
| 90 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.54237416 |
| 91 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.53267563 |
| 92 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.53069622 |
| 93 | Histidine metabolism_Homo sapiens_hsa00340 | 0.52638725 |
| 94 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.49534301 |
| 95 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.48660640 |
| 96 | Mineral absorption_Homo sapiens_hsa04978 | 0.48504654 |
| 97 | Bile secretion_Homo sapiens_hsa04976 | 0.48081542 |
| 98 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.47530317 |
| 99 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.46717233 |
| 100 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.46353635 |
| 101 | Circadian rhythm_Homo sapiens_hsa04710 | 0.46264282 |
| 102 | Alzheimers disease_Homo sapiens_hsa05010 | 0.46013687 |
| 103 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.44518885 |
| 104 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.44369147 |
| 105 | Basal transcription factors_Homo sapiens_hsa03022 | 0.43744296 |
| 106 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.43584002 |
| 107 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.43458589 |
| 108 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.43270408 |
| 109 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.42574925 |
| 110 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.41958409 |
| 111 | Prion diseases_Homo sapiens_hsa05020 | 0.40190778 |
| 112 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.39330531 |
| 113 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.38969409 |
| 114 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.35392512 |
| 115 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.35239570 |
| 116 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.34176233 |
| 117 | Huntingtons disease_Homo sapiens_hsa05016 | 0.33768457 |
| 118 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.33671491 |
| 119 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.33584191 |
| 120 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.33577410 |
| 121 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.32864047 |
| 122 | Endocytosis_Homo sapiens_hsa04144 | 0.32827715 |
| 123 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.30087457 |
| 124 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.30048362 |
| 125 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.29140818 |
| 126 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.28501971 |
| 127 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.28219465 |
| 128 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.28217656 |
| 129 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.27428067 |
| 130 | Endometrial cancer_Homo sapiens_hsa05213 | 0.26820505 |
| 131 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.26631102 |
| 132 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.25987122 |
| 133 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.25105362 |
| 134 | Platelet activation_Homo sapiens_hsa04611 | 0.24777769 |
| 135 | Parkinsons disease_Homo sapiens_hsa05012 | 0.23243620 |
| 136 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.22520794 |

